Imunon, Inc. Research And Development Expense

• Imunon, Inc. showed a decrease of -33.2% in Research And Development Expense from 2024 to 2025.
• This data is from Imunon, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), Imunon, Inc.'s Research And Development Expense has declined by 47.1%.
• Historical annual values: Fiscal year 2025: $7.78 million | Fiscal year 2024: $11.64 million | Fiscal year 2023: $11.29 million | Fiscal year 2022: $11.73 million | Fiscal year 2021: $10.62 million | Fiscal year 2020: $11.34 million | Fiscal year 2019: $13.07 million | Fiscal year 2018: $11.87 million | Fiscal year 2017: $13.08 million | Fiscal year 2016: $14.62 million | Fiscal year 2015: $14.66 million | Fiscal year 2014: $14.97 million | Fiscal year 2013: $9.36 million | Fiscal year 2012: $15.77 million | Fiscal year 2011: $19.86 million | Fiscal year 2010: $14.71 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026